Icon

LYSTEDA (nda022430)- (650MG)

TRANEXAMIC ACID AMRING PHARMS
650MG
Yes Yes
2025-Mar-04 Expired
None None
None No
LYSTEDA is an antifibrinolytic indicated for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential.
3 0 2
Total Other Developers 1
Drugs with Suitability No
650MG ** ** - - 2
NDA Sales Available Total Generic Sales Available
No 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ****** ****** ******** ************** **., ***. *********** **. **, ******* *** ****, ****** ********** ****, ******, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.